EMEA-000876-PIP05-15-M01

  • Email
  • Help

Overview

Product details for Soliris
Invented nameSoliris
Active substance

Eculizumab

Decision numberP/0185/2016
PIP numberEMEA-000876-PIP05-15-M01
Pharmaceutical form(s)Concentrate for solution for infusion
Condition(s)/indication(s)

Treatment of myasthenia gravis

Route(s) of administrationIntravenous use
PIP applicant

Alexion Europe SAS
France
Tel. +33 147100606
Fax +33 147100611
E-mail: pip.enquiries.eu@alxn.com

Decision typePM: decision on the application for modification of an agreed PIP

Decision